These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nornicotine is self-administered intravenously by rats. Bardo MT; Green TA; Crooks PA; Dwoskin LP Psychopharmacology (Berl); 1999 Oct; 146(3):290-6. PubMed ID: 10541729 [TBL] [Abstract][Full Text] [Related]
3. Effects of nornicotine enantiomers on intravenous S(-)-nicotine self-administration and cardiovascular function in rats. Stairs DJ; Neugebauer NM; Wei X; Boustany C; Hojahmat M; Cassis LA; Crooks PA; Dwoskin LP; Bardo MT Psychopharmacology (Berl); 2007 Feb; 190(2):145-55. PubMed ID: 17096082 [TBL] [Abstract][Full Text] [Related]
4. Contributory role for nornicotine in nicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices. Green TA; Crooks PA; Bardo MT; Dwoskin LP Biochem Pharmacol; 2001 Dec; 62(12):1597-603. PubMed ID: 11755112 [TBL] [Abstract][Full Text] [Related]
5. Acute and chronic effects of nornicotine on locomotor activity in rats: altered response to nicotine. Dwoskin LP; Crooks PA; Teng L; Green TA; Bardo MT Psychopharmacology (Berl); 1999 Aug; 145(4):442-51. PubMed ID: 10460322 [TBL] [Abstract][Full Text] [Related]
6. Nornicotine, a nicotine metabolite and tobacco alkaloid: desensitization of nicotinic receptor-stimulated dopamine release from rat striatum. Dwoskin LP; Teng LH; Crooks PA Eur J Pharmacol; 2001 Sep; 428(1):69-79. PubMed ID: 11779039 [TBL] [Abstract][Full Text] [Related]
7. (-)-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats. Bardo MT; Bevins RA; Klebaur JE; Crooks PA; Dwoskin LP Pharmacol Biochem Behav; 1997 Dec; 58(4):1083-7. PubMed ID: 9408217 [TBL] [Abstract][Full Text] [Related]
8. Nicotine-like behavioral effects of the minor tobacco alkaloids nornicotine, anabasine, and anatabine in male rodents. Caine SB; Collins GT; Thomsen M; Wright C; Lanier RK; Mello NK Exp Clin Psychopharmacol; 2014 Feb; 22(1):9-22. PubMed ID: 24490708 [TBL] [Abstract][Full Text] [Related]
9. Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine. Reichel CM; Murray JE; Barr JD; Bevins RA Neuropharmacology; 2010 Jun; 58(8):1237-45. PubMed ID: 20302882 [TBL] [Abstract][Full Text] [Related]
10. Effect of bupropion on nicotine self-administration in rats. Rauhut AS; Neugebauer N; Dwoskin LP; Bardo MT Psychopharmacology (Berl); 2003 Aug; 169(1):1-9. PubMed ID: 12811464 [TBL] [Abstract][Full Text] [Related]
11. Metabolites of nicotine in rat brain after peripheral nicotine administration. Cotinine, nornicotine, and norcotinine. Crooks PA; Li M; Dwoskin LP Drug Metab Dispos; 1997 Jan; 25(1):47-54. PubMed ID: 9010629 [TBL] [Abstract][Full Text] [Related]
12. Nicotinic-receptor mediation of S(-)nornicotine-evoked -3H-overflow from rat striatal slices preloaded with -3H-dopamine. Teng L; Crooks PA; Buxton ST; Dwoskin LP J Pharmacol Exp Ther; 1997 Nov; 283(2):778-87. PubMed ID: 9353398 [TBL] [Abstract][Full Text] [Related]
13. Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration. Rauhut AS; Dwoskin LP; Bardo MT Nicotine Tob Res; 2005 Dec; 7(6):901-7. PubMed ID: 16298725 [TBL] [Abstract][Full Text] [Related]
14. Nornicotine inhibition of dopamine transporter function in striatum via nicotinic receptor activation. Middleton LS; Crooks PA; Wedlund PJ; Cass WA; Dwoskin LP Synapse; 2007 Mar; 61(3):157-65. PubMed ID: 17146768 [TBL] [Abstract][Full Text] [Related]
15. Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats. Neugebauer NM; Zhang Z; Crooks PA; Dwoskin LP; Bardo MT Psychopharmacology (Berl); 2006 Mar; 184(3-4):426-34. PubMed ID: 16220336 [TBL] [Abstract][Full Text] [Related]